Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?

导出 LinkOut

翻译打印收藏纠错

作者： S,Albisinni ^[1] ; F,Aoun ^[2] ; A,Noel ^[3] ; E,El Rassy ^[4] ; M,Lemort ^[5] ; M,Paesmans ^[6] ; R,van Velthoven ^[3] ; T,Roumeguère ^[7] ; A,Peltier ^[7]

作者单位： Department of urology, institut Jules-Bordet, université libre de Bruxelles (ULB), Brussels, Belgium; Department of urology, cliniques universitaires de Bruxelles, hôpital Erasme, ULB, Brussels, Belgium. Electronic address: Simone.albisinni@erasme.ulb.ac.be. ^[1] Department of urology, institut Jules-Bordet, université libre de Bruxelles (ULB), Brussels, Belgium; Department of urology, Hôtel-Dieu de France, Beirut, Lebanon. ^[2] Department of urology, institut Jules-Bordet, université libre de Bruxelles (ULB), Brussels, Belgium. ^[3] Department of oncology, Hôtel-Dieu de France, Beirut, Lebanon. ^[4] Department of radiology, institut Jules-Bordet, ULB, Brussels, Belgium. ^[5] Department of statistics, institut Jules-Bordet, ULB, Brussels, Belgium. ^[6] Department of urology, institut Jules-Bordet, université libre de Bruxelles (ULB), Brussels, Belgium; Department of urology, cliniques universitaires de Bruxelles, hôpital Erasme, ULB, Brussels, Belgium. ^[7]

关键词 Biopsies ciblées de prostate Cancer de prostate Cancer detection Diagnostic Fusion RMN/échographie MRI/US fusion Prostate cancer Targeted prostate biopsies